Results 21 to 30 of about 19,509 (183)

Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation

Frontiers in Cardiovascular Medicine, 2022
Left ventricular assist device (LVAD) therapy has been instrumental in saving lives of patients with end-stage heart failure (HF). Recent generation devices have short-to-mid-term survival rates close to heart transplantation. Unfortunately, up to 1 in 4
Mahmoud Abdelshafy, Mahmoud Abdelshafy, Mahmoud Abdelshafy, Hagar Elsherbini, Ahmed Elkoumy, Ahmed Elkoumy, Ahmed Elkoumy, Andrew J. Simpkin, Andrew J. Simpkin, Hesham Elzomor, Hesham Elzomor, Hesham Elzomor, Kadir Caliskan, Osama Soliman, Osama Soliman, Osama Soliman   +15 more
doaj   +1 more source

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion

Frontiers in Cardiovascular Medicine, 2023
The role of the beta-adrenergic signaling pathway in heart failure (HF) is pivotal. Early blockade of this pathway with beta-blocker (BB) therapy is recommended as the first-line medication for patients with HF and reduced ejection fraction (HFrEF ...
Guillaume Schurtz, Nathan Mewton, Gilles Lemesle, Gilles Lemesle, Gilles Lemesle, Gilles Lemesle, Clément Delmas, Bruno Levy, Etienne Puymirat, Nadia Aissaoui, Fabrice Bauer, Edouard Gerbaud, Edouard Gerbaud, Patrick Henry, Laurent Bonello, Thomas Bochaton, Eric Bonnefoy, François Roubille, Nicolas Lamblin, Nicolas Lamblin   +19 more
doaj   +1 more source

A prospective observational study on usage of inotropes in a coronary care unit

National Journal of Physiology, Pharmacy and Pharmacology, 2019
Background: Treatment with inotropes is generally reserved for most severely ill patients and so increased mortality can be coincidental. Several clinical trials in a wide range of clinical settings have been performed with controversial results to ...
Dr. B. Arumugam, Dr. Y. Nisha Maheswari, Dr. B.Meenakshi, Dr. J.Ezhil Ramya, Dr. A.S.Arul   +4 more
doaj   +1 more source

Approach to Shock

McGill Journal of Medicine, 2022
Shock is a life-threatening pathophysiologic state referring to inadequate organ perfusion, which can progress to end-organ dysfunction and eventually, multiple organ failure and death. The diagnosis of shock is clinical, necessitating good understanding
Janet Chan
doaj   +1 more source

Advanced cardiovascular support in refractory shock

Indian Journal of Respiratory Care, 2018
“Shock” is a term that is used to signify inadequate tissue perfusion and cellular oxygenation. The basic principle of treating shock is restoring tissue perfusion and adequate cellular oxygenation.
Ashwin Neelavar Udupa, Rajesh Mohan Shetty   +1 more
doaj   +1 more source

Outcomes of Use of Inotropes at Waitlisting Through Heart Transplantation: The UNOS Experience. [PDF]

J Cardiovasc Dev Dis
Background: Despite its use in patients awaiting heart transplant (HT), the impact of continuous inotropic support on short-term complications and long-term transplant outcomes remains unclear.
Gemelli M, Doulamis IP, Rojanathagoon T, Tzani A, Rempakos A, Kampaktsis P, Guariento A, Ruiz Dunque E, Asleh R, Alvarez P, Tarzia V, Gerosa G, Briasoulis A.   +12 more
europepmc   +2 more sources

Case Report: When inotropy backfires-dobutamine-associated eosinophilic myocarditis. [PDF]

Front Cardiovasc Med
Eosinophilic myocarditis (EM) is a rare form of myocarditis that is often triggered by drug hypersensitivity reactions. We describe the case of a 55-year-old man who presented with cardiogenic shock that rapidly progressed despite dual inotropic therapy,
Aljudaibi A, Dutta K, Allam S, Almario JA, Tamburro L, Dees L, Sorensen E, Griffith BP, Ramani G, Ananthram M.   +9 more
europepmc   +2 more sources

Probenecid

JACC: Case Reports, 2019
A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy.
Evan C. Klein, MD, Jack Rubinstein, MD, Jennifer L. Strande, MD, PhD   +2 more
doaj   +1 more source

Inotropes and Vasopressors Use in Critical Care and Perioperative Medicine: Evidence-Based Approach (Review)

Общая реаниматология, 2022
Inotropes and vasopressors are frequently required in critically ill patients and in patients undergoing major surgery. Several molecules are currently available, including catecholamines, phosphodiesterase-3 inhibitors, vasopressin and its analogues ...
A. Belletti, M. L. Azzolini, L. Baldetti, G. Landoni, A. Franco, A. Zangrillo   +5 more
doaj   +1 more source

Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database

Frontiers in Cardiovascular Medicine, 2023
IntroductionPharmacological support has become the mainstay therapy in patients with cardiogenic shock (CS). Unfortunately, the clinical benefits of such potent drugs remain unclear, therefore, the present study aims to elucidate the safety and efficacy ...
Bryan Richard Sasmita, ChuanYing Wang, Siyuan Xie   +2 more
doaj   +1 more source